Муковисцидоз: определение, диагностические критерии, терапия. Национальный консенсус

Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics. 1990; 85 (6): 1001–1007.

12. Wilcken B., Brown A.R., Urwin R., Brown D.A. Cystic fibrosis screening by dried blood spot trypsin assay: results in 75,000 newborn infants. J. Pediatr. 1983; 102: 383–387.

13. URL: www.newbornbloodspot.screening.nhs.uk (дата обращения – 31.12.2016).

14. Mishra A., Greaves R., Massie J. The Relevance of Sweat Testing for the Diagnosis of Cystic Fibrosis in the Genomic Era.

Clin. Biochem. Rev. 2005; 26 (4): 135–153.

15. Gibson L.E., Cooke R.E. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics. 1959; 129: 892–897.

16. Hall E., Lapworth R. Use of sweat conductivity measurements. Annals of Clinical Biochemistry. 2010; 47: 390–392.

17. Sands D., Oltarzewski M., Nowakowska A., Zybert K. Bilateral sweat tests with two different methods as a part of cystic fibrosis newborn screening (CF NBS) protocol and additional quality control.

Folia Histochem. Cystobiol. 2010; 30; 48(3): 358–365.

18. Sezer R.G., Aydemir G., Akcan A.B., Paketci C., Karaoglu A., Aydinoz S., Bozaykut A. Nanoduct sweat conductivity measurements in 2664 patients: relationship to age, arterial blood gas, serum electrolyte profiles and clinical diagnosis. J. Clin. Med Res. 2013; 5 (1): 34–41.

19. Langen A.V.,. Dompeling E., Yntema J.B., Arets B.

, Tiddens H., Loeber G., Dankert-Roelse J. Clinical evaluation of the Nanoduct sweat test system in the diagnosis of cystic fibrosis after newborn screening. Eur J. Pediatr. 2015; 174 (8): 1025–1034.

20. Barben J., Ammann R.A., Metlagel A., Sch?ni M.H. Conductivity determined by a new sweat analyzer compared with chloride concentrations for the diagnosis of cystic fibrosis. J. Pediatr. 2005; 146: 183–188.

21. Eng W., Le Grys V.A., Shechter M.S., Laughon M.M., Barker P.M. Sweat-testing in pre-term and full-term infants less than 6 weeks of age.

Pediatr Pulmonol. 2005; 40: 64–67.

22. Legris V.A., Yankaskas J.R., Quittell L.M., Marshall B.C., Mogayzel P.J. Jr. Diagnostic sweat testing: The Cystic Fibrosis Foundation guidelines. J. Pediatr. 2007; 151(1): 85–89.

23. Farell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., Durie P.R., Legrys V.A., Massie J., Parad R.B., Rock M.J., Campbell P.W. 3rd.